JPH04187610A - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JPH04187610A JPH04187610A JP2320067A JP32006790A JPH04187610A JP H04187610 A JPH04187610 A JP H04187610A JP 2320067 A JP2320067 A JP 2320067A JP 32006790 A JP32006790 A JP 32006790A JP H04187610 A JPH04187610 A JP H04187610A
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- carnosine
- anserine
- skin
- balenine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 27
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims abstract description 30
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims abstract description 30
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims abstract description 29
- 108010087806 Carnosine Proteins 0.000 claims abstract description 29
- 229940044199 carnosine Drugs 0.000 claims abstract description 29
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 claims abstract description 28
- 108010085443 Anserine Proteins 0.000 claims abstract description 16
- 241000210053 Potentilla elegans Species 0.000 claims abstract description 16
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 claims abstract description 16
- SLRNWACWRVGMKD-QMMMGPOBSA-N Balenine Chemical compound CN1C=NC(C[C@H](N=C(O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-QMMMGPOBSA-N 0.000 claims abstract description 12
- 108010084730 N(beta)-alanyl-1-methyl-histidine Proteins 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 239000002253 acid Substances 0.000 claims abstract description 6
- 102000004169 proteins and genes Human genes 0.000 abstract description 9
- 108090000623 proteins and genes Proteins 0.000 abstract description 9
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 239000006210 lotion Substances 0.000 abstract description 8
- 239000006071 cream Substances 0.000 abstract description 7
- 229960002885 histidine Drugs 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 230000032683 aging Effects 0.000 abstract description 4
- 238000002156 mixing Methods 0.000 abstract description 4
- 239000000843 powder Substances 0.000 abstract description 3
- 208000003351 Melanosis Diseases 0.000 abstract description 2
- 239000008266 hair spray Substances 0.000 abstract description 2
- 230000001590 oxidative effect Effects 0.000 abstract description 2
- 239000002453 shampoo Substances 0.000 abstract description 2
- 230000000087 stabilizing effect Effects 0.000 abstract description 2
- 230000001256 tonic effect Effects 0.000 abstract description 2
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 230000037303 wrinkles Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 11
- 230000003078 antioxidant effect Effects 0.000 description 10
- 238000007254 oxidation reaction Methods 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000006318 protein oxidation Effects 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- LCYXYLLJXMAEMT-SAXRGWBVSA-N Pyridinoline Chemical compound OC(=O)[C@@H](N)CCC1=C[N+](C[C@H](O)CC[C@H](N)C([O-])=O)=CC(O)=C1C[C@H](N)C(O)=O LCYXYLLJXMAEMT-SAXRGWBVSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- -1 tetrasodium ethylenediaminetetrabutyrate Chemical compound 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- FRJIAZKQGSCKPQ-FSPLSTOPSA-N His-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CN=CN1 FRJIAZKQGSCKPQ-FSPLSTOPSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 230000006538 anaerobic glycolysis Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 125000001409 beta-carotene group Chemical group 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000011544 gradient gel Substances 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 230000037152 sensory function Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000019511 tuna Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、酸化防止効果を有するカルノシン、アンセリ
ン、バレニン又はこれらの酸付加物を有効成分としてな
る化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a cosmetic containing carnosine, anserine, balenine, or an acid adduct thereof as an active ingredient, which has an antioxidant effect.
[従来の技術]
わが国の平均寿命は年毎にめざましい伸びをみせ、今や
世界のトップクラスに躍りでた。高齢化社会を迎えた今
比 健康で、若くありたいとの願いがある。しかし、歳
をとると人の器官や臓器は何らかのかたちで老化が進行
する。[Conventional technology] Japan's average life expectancy has shown remarkable growth year by year, and has now become one of the top in the world. Now that we have an aging society, there is a desire to stay healthy and young. However, as people grow older, their organs and organs begin to age in some way.
皮膚はからだの最外層にあって、外部からの異物の侵入
や刺激から生体を守ると同時に、体温の調節や知覚作用
などさまざまな生理機能をもっているが、他の臓器と同
様1歳とともに老化が進行し、弾力性や柔軟性を失い、
かたくなり、やがてはしわだらけになる。しかし、女性
においては美しい肌を保ちたいとの願望が強い。The skin is the outermost layer of the body, and it protects the living body from foreign substances and stimuli from the outside, and at the same time has various physiological functions such as regulating body temperature and sensory functions.However, like other organs, it begins to age at the age of one year. progresses, loses elasticity and flexibility,
It becomes hard and eventually wrinkled. However, women have a strong desire to maintain beautiful skin.
皮膚は外側に表皮があり、表皮の内側に真皮がある。表
皮細胞が表皮のもつ多層構造を形成して、生存、増殖、
分化をしてゆくためには、真皮が必要である。真皮はお
もにコラーゲンからなり、コラーゲンを合成する繊維芽
細胞を含んでいる。The skin has an epidermis on the outside and a dermis on the inside of the epidermis. Epidermal cells form the multilayered structure of the epidermis to survive, proliferate,
The dermis is necessary for differentiation. The dermis consists primarily of collagen and contains fibroblasts that synthesize collagen.
年齢にともなう皮膚などの結合組織における変化は、結
合組織の中心的な成分であるコラーゲンの変化、特にそ
のクロスリンクの変化にあるといわれている。若いうち
には体にとって重要なシッフ塩基型クロスリンクやピリ
ジノリンなどのクロスリンクができるが、歳をとると、
ヒスチジノアラニンなどの好ましくないクロスリンクが
でき、これが、老化にともなって結合組織がかたくなる
原因と考えられている。Age-related changes in connective tissue such as the skin are said to be due to changes in collagen, a central component of connective tissue, especially changes in its cross-links. When we are young, we can form Schiff base crosslinks and pyridinoline crosslinks, which are important for our bodies, but as we get older,
Unfavorable cross-links such as histidinoalanine are formed, and this is thought to be the cause of connective tissue becoming stiffer with aging.
このようなりロスリンクはタンパク質の酸化反応によっ
てできると考えられている。シッフ塩基型クロスリンク
からピリジノリンのような安定なりロスリンクにかわる
過程も酸化反応であるので、この変化を防ぐには抗酸化
剤が効果を発揮するといわれている。Such loss links are thought to be generated by protein oxidation reactions. The process by which Schiff base-type cross-links change to stable or loss-links such as pyridinoline is also an oxidation reaction, so antioxidants are said to be effective in preventing this change.
一方、化粧品においてコラーゲンのようなタンパク質性
の素材やヒアルロン酸のような多1#頚にアスコルビン
酸塩を配合した場合、酸化防止のために加えられたはず
のアスコルビン酸は微量の金属の存在下では過酸化水素
を発生し逆に酸化作用を引き起こす。この酸化作用によ
り低分子化がおこり品質を著しく低下させることがある
。この防止のために合成の抗酸化剤が用いられるが、安
全性の面から問題が多い。そのため、これら物質にかわ
るものが望まれている。On the other hand, when ascorbate is added to a proteinaceous material such as collagen or a multilayer material such as hyaluronic acid in cosmetics, ascorbic acid, which should have been added to prevent oxidation, is present in the presence of trace amounts of metals. This generates hydrogen peroxide and causes oxidation. This oxidation effect may cause the polymer to become lower in molecular weight, resulting in a significant deterioration in quality. Synthetic antioxidants are used to prevent this, but there are many safety issues. Therefore, alternatives to these substances are desired.
タンパク質が酸化を受けると、その分子は分解したり、
逆に高分子化を引き起こす。また、その構成成分である
アミノ酸にうち、ヒスチジンやトリプトファンが特異的
に損傷を受け、タンパク質分子内のアルデヒド基量の増
加することも報告されている。このような酸化反応によ
る傷害が細胞や組織における老化を促進もしくは老化の
引金となる考えられている。それ故、このようなタンパ
ク質の酸化反応を防止することが出来れば皮膚の老化を
防止することが出来、皮膚の弾力、柔軟性を増加せしめ
、且つ、肌荒れ、小じわ、サメ肌、シミ、ソバカスの予
防にも効果的な化粧料を提供することが可能であり、極
めて有意義である。When a protein undergoes oxidation, its molecules break down or
On the contrary, it causes polymerization. It has also been reported that among its constituent amino acids, histidine and tryptophan are specifically damaged, resulting in an increase in the amount of aldehyde groups within the protein molecule. It is believed that damage caused by such oxidative reactions accelerates or triggers aging in cells and tissues. Therefore, if we can prevent such protein oxidation reactions, we can prevent skin aging, increase skin elasticity and flexibility, and reduce rough skin, fine lines, shark skin, age spots, and freckles. It is possible to provide cosmetics that are also effective for prevention, which is extremely meaningful.
[発明が解決しようとする[!D
このような実状に経み1本発明者らは、安全性が高く、
かつ有効性の高い化粧料を提供すべく鋭意研究を行った
結果、カルノシン、アンセリン、バレニンがタンパク質
の酸化反応に対し優れた酸化防止効果を有することを見
いだした。そしてこれら化合物を用いることにより、こ
こに、皮膚の老化防止及び化粧料中のタンパク質の安定
化のために有用な方法を見いだし、本発明を完成するに
至った。[The invention attempts to solve the problem] D Based on these actual circumstances, the inventors have developed a highly safe and
As a result of extensive research aimed at providing highly effective cosmetics, we discovered that carnosine, anserine, and balenine have excellent antioxidant effects against protein oxidation reactions. By using these compounds, we have found a method useful for preventing skin aging and stabilizing proteins in cosmetics, and have completed the present invention.
[課題を解決するための手段]
本発明の要旨は、カルノシン、アンセリン、バレニン又
はこれらの酸付加塩を有効成分としてなるところにある
。[Means for Solving the Problems] The gist of the present invention is to use carnosine, anserine, balenine, or an acid addition salt thereof as an active ingredient.
ここで酸付加塩としては、製薬上許容される塩、例えば
塩酸塩、硫酸塩、硝l!!塩、コハク酸塩、クエン酸塩
、酒石酸塩などが好ましいものとして挙げられる。Here, the acid addition salts include pharmaceutically acceptable salts such as hydrochloride, sulfate, nitrate! ! Preferred examples include salts, succinates, citrates, tartrates, and the like.
カルノシン(β−アラニル−L−ヒシチジン)、アンセ
リン(β−アラニル−L−1−メチルヒスチジン)、バ
レニン(β−アジニル−L−3−メチルヒスチジン)は
、m+乳類、鳥類、は生類、両生類などの筋肉組織中に
存在するジペプチドであり、既に公知の物質である。こ
れらペプチドが今世紀はじめ発見されて以来、多くの研
究がなされ、カルノシンやアンセリンはを椎動物の骨格
筋中に1〜20mMの濃度範囲で存在することが報告さ
れており、その含量は筋肉の種類や動物の年齢とともに
変化する。カルノシン、アンセリン、バレニン等の物質
は筋肉や脳中でなんらかの生理的な役割を演じていると
考えられているが、それらの役割を充分に説明できる説
はまだない。これらの物質は、神経伝達物質としての作
用するとも、また、嫌気的な解糖作用により筋肉中に生
成する乳酸を中和するための緩衝剤として作用する物質
であるともいわれているが明かではない。Carnosine (β-alanyl-L-histidine), anserine (β-alanyl-L-1-methylhistidine), and balenine (β-azinyl-L-3-methylhistidine) are found in m+ mammals, birds, reptiles, and amphibians. It is a dipeptide that exists in muscle tissue such as, and is already a known substance. Since the discovery of these peptides at the beginning of this century, many studies have been conducted, and it has been reported that carnosine and anserine exist in the skeletal muscle of vertebrates at a concentration range of 1 to 20mM, and the content varies depending on the type of muscle. and changes with the age of the animal. Substances such as carnosine, anserine, and balenine are thought to play some physiological role in muscles and the brain, but there is still no theory that can fully explain their role. These substances are said to act as neurotransmitters and as buffers to neutralize lactic acid produced in muscles through anaerobic glycolysis, but this is not clear. do not have.
ところが、発明者らが、カルノシン、アンセリン、バレ
ニンのタンパク質に対する酸化防止効果について実験を
行なったところ、予想外にも優れた効果を有することを
見いだした。However, when the inventors conducted experiments on the antioxidant effects of carnosine, anserine, and valenine on proteins, they discovered that they had unexpectedly excellent effects.
これらの物質は、元来生体内に存在する物質であるため
、低毒性で安全性も高いこと、また、水に対する溶解性
が良好であることがら酸化防止剤としての意義も大きい
と考えられる。Since these substances originally exist in living organisms, they are considered to be of low toxicity and high safety, and have good solubility in water, so they are considered to have great significance as antioxidants.
本発明に使用するカルノシン、アンセリン、バレニンと
しては、天然物1例えばカツオ節あるいは煮干の製造時
に排出する煮汁、マグロ缶詰製造時に排出する煮汁、あ
るいは、a鶏の肉等の安価な原料から抽出W製されたも
のが用いられるが、化学的合成品あるいは酵素合成品を
使用することも出来る。Carnosine, anserine, and balenine used in the present invention are extracted from natural products 1, such as the broth discharged during the production of bonito flakes or dried sardines, the broth discharged during the production of canned tuna, or extracted from inexpensive raw materials such as chicken meat. A chemically synthesized product or an enzymatically synthesized product can also be used.
本発明において、カルノシン、アンセリン、バレニンを
酸化防止のために化粧料に用いる場合には、カルノシン
、アンセリン、バレニンをそれぞれ単独あるいは組み合
わせて用いてもよいが、酸化防止効果の認められている
他の抗酸化剤やシネルギストと組み合わせて用いてもよ
い。In the present invention, when carnosine, anserine, and balenine are used in cosmetics for antioxidant purposes, carnosine, anserine, and balenine may be used alone or in combination, but other substances known to have antioxidant effects may also be used. May be used in combination with antioxidants and synergists.
抗酸化剤としてはBHA、BHT等の抗酸化剤をまた、
シネルギストとしてはアスコルビン酸、クエン酸、燐酸
塩、フィチン酸等があげられる。As antioxidants, antioxidants such as BHA and BHT are also used.
Examples of synergists include ascorbic acid, citric acid, phosphate, and phytic acid.
また、カルノシン、アンセリン、バレニンは日常許容さ
れる担体(賦形剤、滑沢剤、結合剤、着色剤、乳化剤、
賦香剤等)と共に常法に従って、化粧料に配合される。In addition, carnosine, anserine, and balenine are used in commonly accepted carriers (excipients, lubricants, binders, colorants, emulsifiers,
It is blended into cosmetics according to conventional methods along with fragrances, etc.).
本発明でいう化粧料の形態としては、粉末状、半固形、
ペースト状あるいは液状等すべての化粧料の形態を含む
。The form of cosmetics in the present invention includes powder, semi-solid,
This includes all forms of cosmetics, such as paste or liquid.
また、化粧料には、化粧水、乳液、クリーム、ローショ
ン、パウダー等の基礎化粧品、口紅等のメイクアンプ化
粧品、ヘアトニック、ヘアスプレィ、ヘアクリーム、洗
顔クリーム、シャンプー等が含まれる。Cosmetics include basic cosmetics such as lotions, milky lotions, creams, lotions, and powders, makeup amplifier cosmetics such as lipsticks, hair tonics, hair sprays, hair creams, facial cleansing creams, shampoos, and the like.
これら化粧料の製造方法としては、化粧料製造における
通常の方法を使用することができる。また、その配合量
は化粧料の形態性状ににより異なるが、一般にはo、0
1〜50%が好ましいが、特に限定されるものではない
。As a method for producing these cosmetics, conventional methods for producing cosmetics can be used. In addition, the blending amount varies depending on the morphological properties of the cosmetic, but generally o, 0
It is preferably 1 to 50%, but is not particularly limited.
[実施例]
以下実験例、実施例により本発明を説明するが、これら
は本発明を制限するものではない。[Examples] The present invention will be explained below using experimental examples and examples, but these do not limit the present invention.
実験例1
β−カロチン40mg+ リノール酸40mg、
ツイン40400Bを少量のクロロホルムに溶解後、ロ
ータリーエバポレータにより、クロロホルムを除去し、
減圧乾固する。このものに、酸素ガスを通気した水10
0m1を加えエマルジョン溶液を1s製した。Experimental example 1 β-carotene 40mg + linoleic acid 40mg,
After dissolving Twin 40400B in a small amount of chloroform, remove the chloroform using a rotary evaporator.
Dry under reduced pressure. This is water with oxygen gas aerated in it for 10 minutes.
0ml was added to prepare an emulsion solution for 1s.
このエマルジョン溶液9i1に対し、各種濃度の試料溶
液1mlを加え試験液とした。To this emulsion solution 9i1, 1 ml of sample solutions of various concentrations were added to prepare a test solution.
試験液を、40°Cの恒温槽に放置し、一定時間ごとに
その液0.5mlを取り出し、エタノール9.5mlを
加えよく混ぜた後、波長450nmにおける吸光度の測
定を行いカルノシンの酸化防止効果を実験した。その時
の結果を下表に示した。The test solution was left in a constant temperature bath at 40°C, and 0.5ml of the solution was taken out at regular intervals, 9.5ml of ethanol was added, and the mixture was thoroughly mixed.The absorbance at a wavelength of 450nm was measured to determine the antioxidant effect of carnosine. I experimented. The results are shown in the table below.
0分 60分 120分 240分対照区 0
.495 0.2g4 0.205 0.1331mM
O,4950,2980,2270,1805mM
O,4950,3410,3010,23710m
M O,4950,3600,3250,25650
mM O,4950,3730,3330,2991
00+nM O,4950,3440,3170,2
84カルノシンの量が増加する程、β−カロチンの分解
が抑えられ、酸化防止効果が認められた。0 minutes 60 minutes 120 minutes 240 minutes control group 0
.. 495 0.2g4 0.205 0.1331mM
O, 4950, 2980, 2270, 1805mM
O, 4950, 3410, 3010, 23710m
M O, 4950, 3600, 3250, 25650
mMO, 4950, 3730, 3330, 2991
00+nM O, 4950, 3440, 3170, 2
As the amount of 84 carnosine increased, the decomposition of β-carotene was suppressed, and an antioxidant effect was observed.
実験例2
0.1Mリン酸緩衝液17.5mlに、0.1M硫酸鋼
溶液2.5mlを混ぜた混液に牛血清アルブミン0.0
1g及び各種アミノ酸等を最終濃度が10mMになるよ
うに溶解して調製したタンパク質試料液20m1に、1
0mMアスコルビン酸ナトリウム溶液5mlを加えよく
混合後、室温で銅存在下に、アスコルビン酸を牛血清ア
ルブミンと24時間作反応させた。反応後1反応液4.
5ml採取し、反応停止液として0.4mMエチレンジ
アミン四酪酸四ナトリウム溶液0.5Illを加え1反
応を停止させた。Experimental Example 2 Bovine serum albumin 0.0 was added to a mixture of 17.5 ml of 0.1 M phosphate buffer and 2.5 ml of 0.1 M steel sulfate solution.
Add 1g to 20ml of protein sample solution prepared by dissolving various amino acids etc. to a final concentration of 10mM.
After adding 5 ml of 0 mM sodium ascorbate solution and mixing well, ascorbic acid was reacted with bovine serum albumin at room temperature in the presence of copper for 24 hours. After reaction 1 reaction solution 4.
5ml was collected, and 0.5Ill of 0.4mM tetrasodium ethylenediaminetetrabutyrate solution was added as a reaction stopper to stop one reaction.
次に、この液に電気泳動用試料調製液5mlを加えた後
、更に8M尿素5mlを加え電気泳動用試料とした。こ
の試料液を第一化学■製のグラジェントゲルを用いて電
気泳動した。電気泳動の後、クマシブリリアントブルー
R−250を用いて染色を行なった。タンパク質の酸化
に対するカルノシンの効果を調べるために牛血清アルブ
ミンの主バンドについて■品性製作所製クロマトスキャ
ナC8−9000を用いてその濃度について測定を行っ
た。Next, 5 ml of electrophoresis sample preparation solution was added to this solution, and then 5 ml of 8M urea was added to prepare a sample for electrophoresis. This sample solution was electrophoresed using a gradient gel manufactured by Daiichi Kagaku ■. After electrophoresis, staining was performed using Kumasi Brilliant Blue R-250. In order to examine the effect of carnosine on protein oxidation, the concentration of the main band of bovine serum albumin was measured using a chromato scanner C8-9000 manufactured by Shinsei Seisakusho.
そのチャート上の面積及び最大吸光度の比較により酸化
防止効果の比較を行なった。その結果を下表に示した。The antioxidant effect was compared by comparing the area on the chart and the maximum absorbance. The results are shown in the table below.
面積 吸光度
対照区 159441 0.88カル
ノシン 206723 1J3ヒスチジン
204437 1.69スレオニン
157626 1.12メチオニン
150894 1.15フエニルアラニン 167
301 1.21トリプトフアン 170084
1.29セリン 171440 1
.40リジン 166665 1.3
5アルギニン 185583 1.13シ
ステイン塩酸塩 196959 1.35カルノ
シン及びヒスチジンに優れた酸化防止効果が認められた
が、ヒスチジンでは反応液の着色が著しいことから、ヒ
スチジンよりもカルノシンの方が好ましい。Area Absorbance control area 159441 0.88 Carnosine 206723 1J3 Histidine
204437 1.69 Threonine
157626 1.12 Methionine
150894 1.15 Phenylalanine 167
301 1.21 Tryptophan 170084
1.29 serine 171440 1
.. 40 Lysine 166665 1.3
5 Arginine 185583 1.13 Cysteine Hydrochloride 196959 1.35 Carnosine and histidine were found to have excellent antioxidant effects, but since histidine causes significant coloring of the reaction solution, carnosine is preferable to histidine.
実験例3
実験例2と同様の実験を1反応液中のカルノシンを濃度
をかえて行い、酸化防止効果の変化について調べた。Experimental Example 3 An experiment similar to Experimental Example 2 was conducted by changing the concentration of carnosine in one reaction solution, and changes in the antioxidant effect were investigated.
面積 吸光度
未反応区 100616 1.43無
添加区 60060 0.81カルノ
シン 1mM 85631 1.19カルノ
シン 5mM 90237 1.17カルノ
シン110l11 110192 1.44力
ルノシン50mM 112233 1.46
力ルノシン100mM 107079 1.
44カルノシンの添加量の増加とともに酸化が抑制され
たが、10m M以上の効果はほぼ同してあった。Area Absorbance Unreacted area 100616 1.43 No addition area 60060 0.81 Carnosine 1mM 85631 1.19 Carnosine 5mM 90237 1.17 Carnosine 110l11 110192 1.44 Lunosine 50mM 112233 1.46
Force Lunosine 100mM 107079 1.
The oxidation was suppressed as the amount of 44 carnosine added increased, but the effect was almost the same at 10 mM or more.
実験例4
実験例2のタンパク質試料液のうち、タンパク質を牛血
清アルブミンからβ−ラクトグロブリンに代え、また、
ペプチド類の濃度を100Nとして同様な実験を行なっ
た。その結果を下表に示した。Experimental Example 4 Among the protein sample solutions of Experimental Example 2, the protein was replaced with β-lactoglobulin from bovine serum albumin, and
A similar experiment was conducted using a peptide concentration of 100N. The results are shown in the table below.
吸光度
無添加図 0.22
カルノシン 1.08
アンセリン 1.16
ヒスチジン 1.14
GlrGly−His 1.06β−アラニン
0.77
実施例1
プロピレングリコール2.0部、ポリオキシエチレンヒ
マシ油誘導体0.5部、カルノシン0.1部、はう酸0
.1部、はう砂0.01部、パラオキシ安息香酸メチル
0.2部を精製水97.09部と混合し化粧水を得た。Absorbance diagram without additives 0.22 Carnosine 1.08 Anserine 1.16 Histidine 1.14 GlrGly-His 1.06 β-alanine 0.77 Example 1 2.0 parts of propylene glycol, 0.5 parts of polyoxyethylene castor oil derivative , carnosine 0.1 part, oxalic acid 0
.. A lotion was obtained by mixing 97.09 parts of purified water with 0.01 part of sand, 0.01 part of methyl paraoxybenzoate, and 0.2 part of methyl paraoxybenzoate.
実施例2
セラノール5.0部、ラノリン2.5部、固形パラフィ
ン4.0部、流動パラフィン22.0部、親油性界面活
性剤2.0部、親水性界面活性剤3.5部、防腐剤0.
5部、カルノシン0.3部、BHA O,1部、グリセ
リン10.0部、精製水49.9部を80°Cにて加熱
溶解し、混合乳化後、冷却しながら香料0.2部を加え
、均一分散してクリームを得た。Example 2 Seranol 5.0 parts, lanolin 2.5 parts, solid paraffin 4.0 parts, liquid paraffin 22.0 parts, lipophilic surfactant 2.0 parts, hydrophilic surfactant 3.5 parts, preservative Agent 0.
5 parts of carnosine, 0.3 parts of BHA O, 1 part of BHA O, 10.0 parts of glycerin, and 49.9 parts of purified water were heated and dissolved at 80°C, mixed and emulsified, and 0.2 parts of fragrance was added while cooling. The mixture was added and uniformly dispersed to obtain a cream.
実施例8
ミツロウ3,0部、イソプロピルミリステート5.0部
、流動パラフィン13.0部、親油性界面活性剤1.5
部、親水性界面活性剤3.0部、カルノシン0.2部、
アンセリン0.1部、防腐剤0.3部、プロピレングリ
コール7.0部、1fiU水66.7部を80°Cにて
加熱溶解し、混合乳化し、冷却中に香料を0.2部加え
、均一に分散し、乳液を得た。Example 8 3.0 parts of beeswax, 5.0 parts of isopropyl myristate, 13.0 parts of liquid paraffin, 1.5 parts of lipophilic surfactant
part, hydrophilic surfactant 3.0 parts, carnosine 0.2 parts,
0.1 part of anserine, 0.3 part of preservative, 7.0 parts of propylene glycol, and 66.7 parts of 1fiU water were heated and dissolved at 80°C, mixed and emulsified, and 0.2 part of fragrance was added while cooling. The mixture was uniformly dispersed to obtain a milky lotion.
Claims (1)
酸付加塩を化粧料基剤に配合してなることを特徴とする
化粧料。(1) A cosmetic comprising carnosine, anserine, balenine, or an acid addition salt thereof in a cosmetic base.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2320067A JPH04187610A (en) | 1990-11-21 | 1990-11-21 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2320067A JPH04187610A (en) | 1990-11-21 | 1990-11-21 | Cosmetics |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04187610A true JPH04187610A (en) | 1992-07-06 |
Family
ID=18117354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2320067A Pending JPH04187610A (en) | 1990-11-21 | 1990-11-21 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04187610A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04202114A (en) * | 1990-11-29 | 1992-07-22 | Kyowa Hakko Kogyo Co Ltd | Hairdressing |
JPH05331035A (en) * | 1992-05-27 | 1993-12-14 | Sansho Seiyaku Co Ltd | External preparation for skin |
EP0710485A1 (en) | 1994-09-09 | 1996-05-08 | Suntory Limited | Agents for stimulating hematopoiesis |
EP1388339A1 (en) * | 2002-08-06 | 2004-02-11 | Naina Sachdev | Alkaline anti-wrinkle composition comprising carnosine |
WO2004087086A3 (en) * | 2003-04-03 | 2005-06-02 | Henkel Kgaa | Efficient oxidative hair preparation comprising fiber structure stabilization by means of radical interceptors |
JP2019509301A (en) * | 2016-03-21 | 2019-04-04 | シムライズ アーゲー | Medicine |
CN111956585A (en) * | 2020-08-10 | 2020-11-20 | 湖南本美生物科技有限公司 | Carnosine freckle removing liquid and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02221213A (en) * | 1989-02-23 | 1990-09-04 | Nagai Kinuko | Skin cosmetic |
-
1990
- 1990-11-21 JP JP2320067A patent/JPH04187610A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02221213A (en) * | 1989-02-23 | 1990-09-04 | Nagai Kinuko | Skin cosmetic |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04202114A (en) * | 1990-11-29 | 1992-07-22 | Kyowa Hakko Kogyo Co Ltd | Hairdressing |
JPH05331035A (en) * | 1992-05-27 | 1993-12-14 | Sansho Seiyaku Co Ltd | External preparation for skin |
EP0710485A1 (en) | 1994-09-09 | 1996-05-08 | Suntory Limited | Agents for stimulating hematopoiesis |
EP1388339A1 (en) * | 2002-08-06 | 2004-02-11 | Naina Sachdev | Alkaline anti-wrinkle composition comprising carnosine |
WO2004087086A3 (en) * | 2003-04-03 | 2005-06-02 | Henkel Kgaa | Efficient oxidative hair preparation comprising fiber structure stabilization by means of radical interceptors |
JP2019509301A (en) * | 2016-03-21 | 2019-04-04 | シムライズ アーゲー | Medicine |
CN111956585A (en) * | 2020-08-10 | 2020-11-20 | 湖南本美生物科技有限公司 | Carnosine freckle removing liquid and preparation method thereof |
CN111956585B (en) * | 2020-08-10 | 2021-04-30 | 湖南本美生物科技有限公司 | Carnosine freckle removing liquid and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100499294B1 (en) | Topical Compositions Containing Whey Proteins | |
ES2198662T3 (en) | USE OF RETINOIDS AS AN INDUCTIVE AGENT OF SKIN PIGMENTATION. | |
JPH1067647A (en) | Use of honey as keratin-dissolving agent particularly for lightening facial expression and treating wrinkle | |
JPH06227961A (en) | Cosmetic or medical composition | |
JP2000327552A (en) | Skin preparation for external use | |
JP2886591B2 (en) | Cosmetics | |
KR100275657B1 (en) | The preparation of hair growth | |
EP0498728A1 (en) | Glycyl-serine amides and cosmetic, pharmaceutical or alimentary compositions containting them | |
JPH0791278B2 (en) | Salt of N-acyl thiazolidinecarboxylic acid and piperidinodiaminopyrimidine oxide, and composition containing the same | |
JPS6355483B2 (en) | ||
JPH04187610A (en) | Cosmetics | |
JPH0692821A (en) | Cosmetic containing eucommia ulmoides leaf extract | |
US11045471B2 (en) | Melanin production inhibitor, whitening agent, fibroblast activator, collagen and/or elastin production promotor and wrinkle ameliorant | |
JP2004284988A (en) | Hair cosmetic and method for inhibiting carbonylation of hair protein | |
JPH0532533A (en) | Cosmetic | |
JPH02111714A (en) | Cosmetic | |
CA2233219C (en) | Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration | |
FR2590169A1 (en) | Cosmetic composition containing biostimulins | |
JP2003055133A (en) | Cosmetic or dermatological composition comprising combination of elastase inhibitor of n-acylaminoamide family and at least one kind of muscle relaxant | |
JPH0437044B2 (en) | ||
JP7135106B2 (en) | Scalp and hair composition | |
JP2781982B2 (en) | External preparation for skin | |
JP2021113172A (en) | Peptidyl arginine deiminase 1 expression promoter | |
JPH09176030A (en) | Medicine for stimulating secretion of sebum | |
JPH08198741A (en) | Biological hyarulonic acid synthesis promoter |